Claris Lifesciences Limited - healthcare in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
CIN U85110GJ1994PLC022543 Incorporated 19 July 1994 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Merged Public Limited Company healthcare
Revenue · FY 2021
₹4.13 Lakh
▼ 91% YoY
Net loss · FY 2021
₹27.3 Lakh
Latest filing
EBITDA · FY 2021
-₹27.26 Lakh
Latest filing
Authorised capital
₹120.51 Cr
Registered with MCA
Paid-up capital
₹54.57 Cr
Issued & subscribed
Satisfied charges
₹3,276.28 Cr
No open charges
Company age
32 yrs
Est. 1994
Employees · EPFO
45
Provident fund records

About Claris Lifesciences Limited

Data last updated:

Claris Lifesciences Limited was a public limited company based in Ahmedabad, Gujarat, India, operated as a subsidiary of Claris Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 19 July 1994.

The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U85110GJ1994PLC022543. Its GSTIN is 24AAACC6366Q1Z8 (Gujarat). The company held 16 GST registrations, of which 1 is active.

The company had an authorised share capital of ₹120.51 Cr and a paid-up capital of ₹54.57 Cr. It was formerly known as Oragle Laboratories Limited and Core Laboratories Limited. It was led by directors including Arjun Sushilkumar Handa (Managing Director) and Aditya Sushilkumar Handa.

Its last annual general meeting (AGM) was held on 28 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Claris Corporate Headquarters Nr. Parimal Crossing Ellisbridge, Ahmedabad, Gujarat, India – 380006.

As per the financials filed for FY 2021, the company reported a revenue of ₹4.13 Lakh, a decline of 91% compared to the previous year. For the same year it recorded a net loss of ₹27.3 Lakh and EBITDA of -₹27.26 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 86% over three years and 81% over five years.

The company had about 45 employees on its provident fund (EPFO) records before it was dissolved.

The company was associated with 1 brand: Claris Lifescences. As per MCA filings, the company had satisfied charges of ₹3,276.28 Cr on record. Court records list 71 cases involving the company, including 30 filed by the company and 41 filed against it; 12 cases are pending. The company has 40 deals on record (21 market trades, 17 secondary share transfers, 1 ipo), with disclosed funding of ₹60.34 Cr; the latest was in March 2019. The company has 2 MSME Form 1 returns on record between 2021 and 2022, listing 5 overdue payments to 2 micro and small suppliers.

The last known website on record is clarislifesciences.com.

Company details

CIN U85110GJ1994PLC022543
Registration Number 022543
Incorporation Date 19 July 1994
ROC Ahmedabad
Listing Status Unlisted
Company Status Amalgamated
Parent Company Claris Limited
Compliance Status Active Compliant

Name history

Claris Lifesciences has undergone 2 name changes throughout its history. The company was previously known as Oragle Laboratories Limited, and Core Laboratories Limited. The current legal name is Claris Lifesciences Limited.

Company NameStatus
Claris Lifesciences LimitedCurrent
Oragle Laboratories LimitedPrevious
Core Laboratories LimitedPrevious

CIN history

Claris Lifesciences has one previous CIN (Corporate Identification Number): L85110GJ1994PLC022543. The current CIN is U85110GJ1994PLC022543, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85110GJ1994PLC022543Current
L85110GJ1994PLC022543Previous

Contact details

Claris Lifesciences Limited's registered office is in Ahmedabad, Gujarat. Its website is clarislifesciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Claris Corporate Headquarters Nr. Parimal Crossing Ellisbridge, Ahmedabad, Gujarat, India – 380006
  • Industry
    Healthcare, Medical Consumables & Supplies

To see the full contact details of Claris Lifesciences Limited, buy the company report.

Comprehensive company report
Claris Lifesciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Claris Lifesciences operates one associated brand: Claris Lifescences. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of sterile injectable medications is facilitated online.clarislifesciences.com

Financials of Claris Lifesciences Limited

FY 2021 filings available

Claris Lifesciences Limited reported revenue of ₹4.13 Lakh (down 91% YoY) for FY 2021.

Revenue · FY 2021
₹4.13 Lakh ▼ 91%
Net loss · FY 2021
₹27.3 Lakh
EBITDA · FY 2021
-₹27.26 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 91%
3 years · compounded
▼ 86%
5 years · compounded
▼ 81%
EBITDA CAGR growth
1 year
▲ 73%
3 years · compounded
▲ 59%
5 years · compounded
▲ 61%

Revenue has declined at a compounded annual rate (CAGR) of 81% over five years, including a 91% fall in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹4.13 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹27.26 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹27.3 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Claris Lifesciences Limited, buy the company report.

Board of directors and KMP of Claris Lifesciences Limited

Claris Lifesciences Limited currently reports 5 directors and 2 key managerial personnel. 23 former directors have served the organization.

Directors and KMP (as last reported)
NameDesignationAppointment DateTenureStatus
Chandrasingh Shivrambhai PurohitCfo09 May 201412 Years 6 MonthsAs last reported
Arjun Sushilkumar HandaManaging Director26 Sep 201412 Years 1 MonthsAs last reported
Aditya Sushilkumar HandaDirector13 Jun 200620 Years 5 MonthsAs last reported
Anup Pravin ShahDirector23 Feb 201313 Years 8 MonthsAs last reported
Surrinder Lal KapurDirector26 Sep 200818 Years 1 MonthsAs last reported
Kiritkumar Himatlal KanjariaCompany Secretary13 Apr 201313 Years 7 MonthsAs last reported
Showing 6 of 7 current directors and KMP. View all directors and KMP

Auditor

Claris Lifesciences Limited is audited by Shah & Shah Associates for the financial year 2021.

Auditor firmFinancial yearFirm registration number
Shah & Shah AssociatesFY 2021113742W

Shareholding

The shareholding of Claris Lifesciences Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Claris Lifesciences Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹3,276.28 Cr
Breakdown by lending institutions
Canara Bank₹1,373.81 Cr
Credit Suisse Ag₹780.00 Cr
Centurion Bank of Punjab Ltd.₹168.50 Cr
Indian Overseas Bank₹150.64 Cr
The Hongkong & Shanghai Banking Corporation Limited₹112.59 Cr
Others₹690.73 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Dec 2017100145636Credit Suisse Ag₹390 CrSatisfied
20 Dec 2017100145645Credit Suisse Ag₹390 CrSatisfied
30 Sep 2016100053478Punjab National Bank₹20 CrSatisfied
12 Aug 2016100046036Icici Bank Limited₹23 LakhSatisfied
24 May 2016100032154Icici Bank Limited₹35 LakhSatisfied

To see the full charge records of Claris Lifesciences Limited, buy the company report.

Total charge records: 67 View all charges

Deals & funding

Claris Lifesciences Limited has 40 deals on record (21 market trades, 17 secondary share transfers, 1 ipo), with disclosed funding of ₹60.34 Cr; the latest was in March 2019.

Total deals
40
Market trades
21
Secondary share transfers
17
IPO
1
Funding round
1
Disclosed funding
₹60.34 Cr

Deals on record (5 of 40)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedBuyer: Clairs Limited, Claris Holdings Private Limited
Seller: Others - Claris Lifesciences Limited
Oct 2016Market trade₹31.83 CrBuyer: Everest Finance And Investment Company
Seller: Abellon Energy Limited.
Jul 2016Market trade₹97.36 CrBuyer: East Bridge Capital Master Fund Limited, Morgan Stanley Asia Singapore Pte
Seller: Abellon Energy Limited.
Jul 2016Secondary share transferUndisclosedBuyer: Morgan Stanley Investment Management, an individual
Seller: Abellon Energy Limited.
Apr 2015Market trade₹170.63 CrBuyer: Tata Aia Life Insurance Company Limited , an individual
Seller: First Carlyle Ventures Iii

To see the full deal history of Claris Lifesciences Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Claris Lifesciences Limited has 2 MSME Form 1 returns on record between 2021 and 2022, listing 5 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (2 of 2)

SupplierAmount dueDue sinceReported on
Shah and Shah Associates
Spanj & Associates

To see the full MSME payment records of Claris Lifesciences Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Claris Lifesciences Limited has a workforce of 45 employees on its EPFO records as of Nov 2018, across 1 active EPFO establishment.

Employee count
45
Active EPFO establishments
1
Employee growth
-74.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2018-1945
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Claris Lifesciences Limited, buy the company report.

GST

Claris Lifesciences has 16 GST registrations: 1 active and 15 cancelled or inactive.

Total GSTINs
16
Active
1
Cancelled / inactive
15
GSTINStateStatusRegistered on
24AAACC6366Q1Z8GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Claris Lifesciences Limited, buy the company report.

Recent activity

Claris Lifesciences Limited has 29 board changes on record since 2001: 7 appointments and 22 cessations. The latest: Tiruponitura Venkatraman Ananthanarayanan ceased to be Director on 31 Mar 2019.

AGM
Claris Lifesciences Limited last Annual general meeting of members was held on 28 Sep 2021 as per latest MCA records.
Filing
Claris Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ahmedabad.
Charges
A charge registered on 12 Aug 2016 via Charge ID 100046036 with Icici Bank Limited was fully satisfied on 14 Aug 2019.
Charges
A charge registered on 24 May 2016 via Charge ID 100032154 with Icici Bank Limited was fully satisfied on 24 May 2019.
Charges
A charge registered on 24 May 2016 via Charge ID 100032156 with Icici Bank Limited was fully satisfied on 24 May 2019.
Charges
A charge registered on 24 May 2016 via Charge ID 100032158 with Icici Bank Limited was fully satisfied on 24 May 2019.
Ceased
Tiruponitura Venkatraman Ananthanarayanan ceased to be Director.
Charges
A charge registered on 20 Dec 2017 via Charge ID 100145636 with Credit Suisse Ag was fully satisfied on 27 Nov 2018.
Charges
A charge registered on 20 Dec 2017 via Charge ID 100145645 with Credit Suisse Ag was fully satisfied on 27 Nov 2018.
Charges
A charge with Credit Suisse Ag amounted to Rs. 390.00 Cr with Charge ID 100145636 was registered on 20 Dec 2017.
Charges
A charge with Credit Suisse Ag amounted to Rs. 390.00 Cr with Charge ID 100145645 was registered on 20 Dec 2017.
Charges
A charge registered on 30 Sep 2016 via Charge ID 100053478 with Punjab National Bank was fully satisfied on 24 Aug 2017.

170 earlier events are in the company report.

Frequently asked questions

Claris Lifesciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Claris Lifesciences was a public limited company based in Ahmedabad, Gujarat, India. The company worked in medical consumables and supplies, within the healthcare industry. It was incorporated on 19 July 1994 and is registered under CIN U85110GJ1994PLC022543. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Claris Lifesciences was incorporated on 19 July 1994. It is registered with the Registrar of Companies, Ahmedabad.

Claris Lifesciences had 7 directors and KMP:

The CIN (Corporate Identification Number) of Claris Lifesciences is U85110GJ1994PLC022543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Claris Lifesciences is at Claris Corporate Headquarters Nr. Parimal Crossing Ellisbridge, Ahmedabad, Gujarat, India – 380006.

Claris Lifesciences can be reached through the website clarislifesciences.com. Its registered office is in Ahmedabad, Gujarat, India.

The latest financial statements of Claris Lifesciences on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 28 September 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Claris Lifesciences is 24AAACC6366Q1Z8, registered in Gujarat. The company has 16 GST registrations in all, of which 1 is active and 15 are cancelled or inactive.

Claris Lifesciences operated in the healthcare industry, in the medical consumables and supplies segment.

Claris Lifesciences has 40 deals on record (21 market trades, 17 secondary share transfers, 1 ipo), with disclosed funding of ₹60.34 Cr; the latest was in March 2019.